Abstract: Embodiments provide a blood pressure measuring device that: (a) transmits, with an acoustic transducer, acoustic energy at a first frequency towards a blood vessel; (b) first measures an electrical property of the acoustic transducer; (c) transmits, with the acoustic transducer, acoustic energy at a second frequency towards the blood vessel; (d) second measures the electrical property of the acoustic transducer; (e) determines a change in the electrical property of the acoustic transducer between the first measuring and the second measuring, the determined change corresponding to a change in reflected acoustic energy from the blood vessel; (f) determines a resonant frequency of vibration of a wall of the blood vessel as a function of the determined change in the electrical property of the acoustic transducer; and (g) generates a blood pressure measurement as a function of the determined resonant frequency of vibration of the wall of the blood vessel.

Abstract: This application provides a deep learning-based heart rate detection method and a wearable device, and relates to the field of communications technologies. According to this solution, a deep Attention network is trained by using PPG and ACC sensor signals as inputs and using heart rate information and exercise scenario information as model outputs, and heart rate detection is performed by using a model obtained through training. Because motion artifact noise is distributed differently in different scenarios, a nonlinear relationship between a scenario, noise, and a heart rate may be fitted by using a deep Attention network learning mechanism, so that data denoising processing and feature extraction can be adaptively implemented in different scenarios, to achieve effects of signal denoising, signal fusion, and complex scenario identification in a plurality of complex scenarios, thereby canceling interference of motion artifact noise to a PPG signal, and improving precision of heart rate detection.

Abstract: The present disclosure concerns a device for sensing at least one biological parameter (e.g., heart rate, heart rate variability) of a subject, the device comprising a contact surface configured for being brought into a contact with a skin surface of the subject. The device has at least one light source for illuminating the skin surface through the contact surface along an illumination source optical axis with illumination including at least one sensing wavelength, and at least one detector for detecting a response of said illumination at least at said wavelength, from the skin surface through the contact surface along a detector optical axis, and providing signals configured for determining said biological parameter based thereon, said illumination optical axis forming with said contact surface an acute included angle.

Abstract: A smart heart tracker is described. The smart heart tracker includes a 3-axis accelerometer that measures and stores position and acceleration information for the smart heart tracker and an optical biosensor that measures the heart rate. The smart heart tracker also includes a memory that stores instructions and a processor that executes the instructions to receive the stored position and acceleration information from the 3-axis accelerometer, determine one or more physical activities corresponding to the stored position and acceleration information, and store the determined one or more physical activities.

Abstract: A patient-wearable device for detecting a subpulse of a patient and determining a pulse condition based thereon, and related systems, methods and computer program products. The device includes a base layer comprising a printed circuit board (PCB) and electronics connected thereto, and an adhesive layer connected to the base layer. The electronics may include one or more sensors that generate sensor data, a computer that processes the sensor data to determine the pulse condition of the patient, and a user interface (UI) component that generates a user-perceptible indication of the determined pulse condition. In alternate embodiments, the computer and the UI component may be external to the device and the device may communicate the sensor data to the computer via wired or wireless connection. In further embodiments, multiple devices may be attached to the patient and concurrently transmit raw or processed sensor data to facilitate determination of the pulse condition.

Abstract: An apparatus for measuring flow resistances of blood vessels includes a photoplethysmography sensor for emitting electromagnetic radiation with different wavelengths to the blood vessels, a pressure instrument for applying controllable mechanical pressure on the blood vessels, and a control system for estimating compliances of the blood vessels based on electromagnetic radiation reflected off the blood vessels. Shorter wavelengths of the electromagnetic radiation are reflected off smaller blood vessels than longer wavelengths. The control system optimizes resistor values of a circuit model to minimize differences between waveforms of node voltages of the circuit model and waveforms of measured blood pressures prevailing in blood vessels reflecting off different wavelengths. Capacitor values of the circuit model are based on the estimated compliances of the blood vessels, and the optimized resistor values of the circuit model are indicative of the flow resistances of the blood vessels.

Abstract: A gastrointestinal treatment system including a gastrointestinal capsule adapted to treat a subject following ingestion of the gastrointestinal capsule. The gastrointestinal capsule includes: (a) a housing; (b) a vibrating agitator, powered by the battery, the vibrating agitator adapted such that, in a first vibrating mode of operation, the housing exerts vibrations on an environment surrounding the capsule; (c) a power supply disposed within the housing and adapted to power the vibrating agitator; and (d) a controller adapted, in response to receipt of an activation input, to activate the vibrating agitator to operate in the first vibrating mode of operation at a user-specific time of day.

Abstract: A wirelessly powered medical implant system comprising: a power source system including: an automatic gain controller to receive input power, automatically adjust the input power based on a feedback signal with an offset phase delay, and provide the adjusted input power as output power; a source resonator to generate, based on the output power, a magnetic field to transmit wireless power via the magnetic field, and provide the feedback signal; and an offset phase delay circuit to receive the feedback signal from the source resonator, generate the offset phase delay, and include the offset phase delay with the feedback signal; and a medical implant including: an implant resonator to receive the transmitted wireless power via the magnetic field; and one or more sensors, wherein the feedback signal is based on inductive coupling of the magnetic field between the source resonator and the implant resonator.

Abstract: The invention describes a method for continuous or intermittent wireless monitoring of the volume of cardiac chambers, with the ability to combine these with pressure measurements for optimal remote monitoring of cardiac patients. The invention comprises a set of wireless sensors such as resonators or reflectors placed within a cardiac chamber (i.e., the left ventricle), means for sensing the pressure within one or more cardiac chamber, and an external device adapted to interrogate the wireless sensors, determine their relative and/or absolute positions with respect to each other and/or the external device, and calculating the resulting volume of the cardiac chamber and creating pressure-volume loops.

Abstract: Systems and methods described herein provide techniques for automated phenotyping. The systems and methods, in some embodiments, processes video data, identifies body parts, extracts features on a frame-level, and determines subject behavior captured in the video data. The systems and methods may use one or more machine learning models.

Abstract: A portable hearing screening and amplification device structured to be coupled to a headset includes: a housing, a plurality of buttons, a plurality of indicators, a microphone circuit, an output circuit, a power source, and a controller. Upon passing a background noise test, the portable hearing screening and amplification device is structured to transmit a plurality of hearing screening tones to the headset for a user for testing of the plurality of hearing screening tones and complete the hearing screening based on responses of the user related to the plurality of hearing screening tones, the responses including a number of hearing screening tones that the user has perceived during the hearing screening. Based on a determination that the number of hearing screening tones perceived is less than a prerequisite number, the portable hearing screening and amplification device is further structured to switch to amplification mode and provide amplification.

Abstract: Medical devices configured for in vivo assays of one or more analytes can sometimes be problematic if left inserted in a tissue, such as skin, for an extended time. Certain medical device surface profiles may aid in alleviating this issue. Accordingly, medical devices may comprise a base surface having a tissue-facing surface profile defined thereon, and a sensor extending through the base surface and at least a portion of the tissue-facing surface profile. The tissue-facing surface profile deviates from the base surface, and the tissue-facing surface profile is also configured to undergo a change in shape, hardness, or a combination thereof after contacting a tissue for a length of time. A dynamic material may be present in at least a portion of the tissue-facing surface profile.

Abstract: A sensor device for sensing a property of a biological material comprises: a biocompatible enclosure comprising a barrier having a first and a second surface; a sensor receptor element arranged at the first surface; a substrate arranged at the second surface carrying an electronic or photonic circuitry comprising a sensor transducer element for reading out signals from the sensor receptor element; and wherein at least one compartment of the biocompatible enclosure is configured to control transport of the biological material into the compartment or is configured to form a hermetical seal around the substrate.

Abstract: The present invention relates to the technical field of blood glucose monitoring, and in particular to a split-type real-time blood glucose monitoring apparatus and a manufacturing method therefor. The real-time blood glucose monitoring apparatus comprises a sensor assembly and an emitter assembly. The sensor assembly comprises a first shell, and a conductive plating, a blood glucose sensor and a battery which are arranged on the first shell. The emitter assembly comprises a second shell and a circuit board in the second shell. The conductive plating is arranged on a shell wall of the first shell and is connected to the blood glucose sensor and the battery, and the conductive plating is provided with at least one first connecting structure; and the circuit board is provided with at least one second connecting structure.

Abstract: The present group of inventions refers to the medicine and medical technology and more particularly to methods and devices for monitoring blood glucose level by measuring the calorimetric method of the thermal effect and metabolic rate of the local area of living tissue. Method for monitoring blood glucose level is that the value of the thermal metabolism of the local area of living tissue of the effect or intensity of metabolism of the local area of living tissue is calculated as follows: at least one heat and waterproof applicator forming the closed system in the local area of tissue under the applicator is applied to the skin surface by a dosage pressure; temporal dynamics of physiological parameters of the local tissue region is measured under the applicator, in particular, at least the amount of water in the intercellular space of tissue under the applicator; temperature of a deep layer of tissue Tskin under the applicator; elastic pressure of tissue under the applicator.

Abstract: An application running on a device to manage insulin site rotation may read a configuration file including a group, a plurality of sites in the group, and an image associated with the group. The application may detect an input selecting a site from the plurality of sites for administration of an insulin management device. The application may also set the selected site as unavailable for a predetermined duration in response to the input selecting the site. A log entry may be written to track usage of the site in response to the input selecting the site. A visual indicator on the selected site may show that the site is recently selected in response to detecting the input selecting the site within a predetermined duration. The insulin management device may be a pump, a syringe, or a glucose monitor.

Abstract: An applicator assembly for applying at least a portion of an analyte monitor includes a frame having a longitudinal axis and an opening, a resilient member having at least a first portion fixed relative to the frame and a second portion movable axially relative to the frame, a needle, and a cap engageable with the frame to cover at least part of the opening. The cap is adjustable to increase a bias on the resilient member and to move the second portion of the resilient member away from the opening. When the cap is separated from the frame, the second portion of the resilient member is configured to be held relative to the frame. The hold on the second portion of the resilient member is releasable, such that the bias on the resilient member advances the second portion of the resilient member and the needle towards the opening.

Abstract: Conventionally, a needle or the like needs to inserted into skin of a subject to invasively collect blood in ?GT measurement, which causes a psychological or physical burden on a subject. According to the present invention, it is possible to invasively estimate ?GT based on attribute information and non-invasive biological information of a predetermined user by generating a ?GT estimation model by machine learning based on attribute information, non-invasive biological information, and blood examination data acquired from a plurality of subjects in advance.

Abstract: Devices are provided for measurement of an analyte concentration, e.g., glucose in a host. The device can include a sensor configured to generate a signal associated with a concentration of an analyte; and a sensing membrane located over the sensor. The sensing membrane comprises a diffusion resistance domain configured to control a flux of the analyte therethrough. The diffusion resistance domain comprises one or more zwitterionic compounds and a base polymer comprising both hydrophilic and hydrophobic regions.

Abstract: An apparatus includes a catheter, an introducer, and an actuator. A distal end portion of the introducer has a lock configured to couple the introducer to a closed system intravenous line at least partially disposed in a body. The lock is configured to transition a seal of the closed system intravenous line from a closed state to an open state when coupled thereto. The actuator is at least partially disposed in the introducer and coupled to a proximal end portion of the catheter. The actuator is configured to move the catheter between a first position, in which the catheter is disposed within the introducer, and a second position, in which the catheter extends through the seal of the closed system intravenous line such that a distal end surface of the catheter is positioned distal to the closed system intravenous line.

Abstract: A testing system for conducting electrochemistry analysis of a specimen sample is provided. The testing system includes a testing receptacle device and a diagnostic device. The testing receptacle device includes a receptacle having an interior space defined therein and a lid configured to be secured on an upper end of the receptacle. The lid includes an opening extending into the receptacle and a cartridge slot for receiving a test sensor cartridge having a functionalized electrode strip with an electrode well contact point provided thereon. The diagnostic device is configured as a potentiostat or similar device and includes a docking port for receiving a lower end of the testing receptacle device. The testing system is configured for receiving a specimen sample through the opening in the receptacle lid and placing the specimen sample in contact with the electrode well contact point of the functionalized electrode strip.

Abstract: Provided is an information processing apparatus including an estimation part configured to estimate a load experienced by a user, on the basis of data from a sensor measuring a physiological index of the user, the estimation part estimating, as the load, at least one of a workload experienced by the user carrying out a predetermined task and a visual load experienced by the user making alert concentration.

Abstract: A method and a system are provided for taking physiological markers measurements of patients who have anxiety or depression. Mathematical analysis (e.g., pattern recognition, machine learning and AI algorithms) of the physiological markers measurements is used to create a unique personal prediction model and data set for an individual patient. The unique personal data set is used to diagnose and monitor a particular problem of the individual patient associated with anxiety or depression, prevent potential overdosing or to recommend a treatment for a particular problem of the individual patient associated with anxiety or depression, or to predict an outcome of a treatment for a particular problem of the individual patient associated with anxiety or depression.

Abstract: A measurement probe includes: an elongated body that is insertable into a catheter having a flow path; a sensor fixed to the elongated body and capable of detecting a state of a fluid flowing in the flow path; and a sensor holding portion that holds the sensor at a predetermined position when the elongated body is inserted into the catheter. An output of the sensor changes depending on an oxygen partial pressure in the fluid, a carbon dioxide partial pressure in the fluid, a hydrogen ion index of the fluid, an amount of potassium ions in the fluid, an amount of sodium ions in the fluid, an amount of chlorine ions in the fluid, a temperature of the fluid, or a flow rate of the fluid.

Abstract: A system for augmenting uterine forces includes a medical apparatus having a balloon body that transitions between a compacted state and an expanded state, a catheter that receives the medical apparatus and obtains electrical signals indicative of intrinsic uterine contractions, and a controller coupled to the catheter to receive the electrical signals, and to a source of an agent. The controller processes the electrical signals to detect an onset of an intrinsic uterine contraction, an increase in uterine contraction forces, or a decrease in uterine contraction forces. In response to a detection of an onset of an intrinsic uterine contraction or an increase in uterine contraction forces, the controller causes an agent to be delivered from the agent source to the balloon body to expand the balloon body. In response to a detection of a decrease in uterine contraction forces, the controller causes agent to discharge from the balloon body to collapse the balloon body.

Abstract: An electrode array includes a fan-shaped substrate member. The fan-shaped substrate member includes a dielectric material and that has a triangular portion with a convexly curved base from which a first side and an opposite second side extend to a truncated apex that includes a concavely curved surface. An elongated lead member includes the dielectric material and extends from the base adjacent to a selected one of the first side and the second side. The elongated lead member is contiguous with the fan-shaped substrate member. Each of a plurality of wires is embedded in the fan-shaped substrate member and the elongated lead member. Each of a corresponding plurality of electrodes is electrically coupled to a different one of the plurality of wires. Each of the corresponding plurality of electrodes includes an exposed surface.

Abstract: A biological signal processing system includes a segment identification unit configured to identify a segment including a time point of a processing target with respect to a biological signal whose period is divided into a plurality of segments in time, a processing control unit configured to select a processing method of processing the biological signal at the time point of the processing target on the basis of the segment identified by the segment identification unit, and a process execution unit configured to execute a process for the biological signal in the processing method selected by the processing control unit.

Abstract: Systems and methods described herein improve visibility of features (e.g., P-waves) of a physiologic signal segment (e.g., an EGM or ECG signal segment) to be displayed within a display band having a specified height between an upper and a lower boundary of the display band. The physiologic signal segment is divided into sub-segments, for each of which a sub-segment minimum peak amplitude and maximum peak amplitude are determined. Based thereon, a new minimum peak amplitude and a new maximum peak amplitude are determined and used to determine a new display range. A portion of the physiologic signal segment that is within the new display range is caused to be display, within the display band having the specified height, such that the upper boundary of the display band corresponds to the new maximum peak amplitude, and the lower boundary of the display band corresponds to the new minimum peak amplitude.

Abstract: Systems and methods described herein improve visibility of P-waves of an EGM or ECG signal segment to be displayed on a display screen. There is a determination of whether relatively small features, including the P-waves, of the ECG or EGM signal segment would be difficult to visualize if an original signal segment range of the ECG or EGM signal segment were caused to be displayed on the display screen. In response to determining that the relatively small features of the ECG or EGM signal segment would be difficult to visualize, a portion of the EGM or ECG signal segment is displayed on the display screen in a manner that magnifies the P-waves of the EGM or ECG signal segment compared to if an entirety of the EGM or ECG signal segment within the original signal segment range were instead caused to be displayed on the display screen.

Abstract: A method for health monitoring of a subject. The method includes measuring each of a plurality of physiological parameters once per a respective time period of a plurality of time periods. Measuring each of the plurality of physiological parameters includes measuring a heart rate of the plurality of physiological parameters by installing a sensor package on a region at a right side of a chest of the subject Installing the sensor package on the region includes placing a pair of electrocardiography (ECG) electrodes and an accelerometer in the sensor package on the region which includes the anterior edge of the right serratus anterior muscle of the subject.

Abstract: A method and system for a user interface for artifact removal in an EEG is disclosed herein. The invention allows an operator to select a plurality of artifacts to be automatically removed from an EEG recording using a user interface. The operator pushes a button on the user interface to apply a plurality of filters to remove the plurality of artifacts from the EEG and generate a clean EEG for viewing.

Abstract: Provided herein, inter alia, are methods for detecting brain structure modulations associated with impaired inhibitory control disorders (ICD). The methods are useful for treating of a variety of neurological and psychiatric conditions, and can include neurostimulation to specific regions of the brain.

Abstract: A system of seizure detection including one or more processing circuits configured to receive an electroencephalogram (EEG) signal generated based on electrical brain activity of a patient and determine a plurality of metrics based on the EEG signal, the plurality of metrics indicating non-linear features of the EEG signal. The one or more processing circuit are configured to perform a preliminary analysis with one of the plurality of metrics, wherein the preliminary analysis indicates that the EEG signal indicates a candidate seizure or that the EEG signal is insignificant, perform a secondary analysis with one or more metrics of the plurality of metrics to determine whether the EEG signal indicates the candidate seizure or that the EEG signal is insignificant, and generate a seizure alert indicating that the EEG signal indicates the candidate seizure.

Abstract: A skin penetration device (2, 102, 202, 302) for administering a test substance (10). The skin penetration device has a first layer (4, 104, 204, 304), a second layer (6, 106, 206, 306), and a third layer (12, 212, 312). It may also have a fourth layer (16, 116, 216). The second layer has a protrusion (8, 108, 208, 308) providing a hollow space for containing the substance to be administered. In The skin penetration device further has a skin-piercing component (18, 118, 218, 318) that can release the substance and rupture the skin when pressed towards the skin in use. The skin-piercing component has a rest configuration and is configured to be biased towards the rest configuration such that it may be deformed but returns to the rest configuration when the deforming force is removed.

Abstract: A system is disclosed which includes a sensor clip, having at least one sensor, and a mobile device. The mobile device wirelessly receives sensor data from the sensor clip sensor. Additionally disclosed herein is a system which includes a sensor clip, having at least one sensor, a mobile device, and a server. The mobile device wirelessly receives sensor data from the sensor clip sensor, and the server wirelessly receives sensor data from the mobile device.

Abstract: Techniques for generating a user interface view including sensor data representative of analyte levels of a host are disclosed. In certain embodiments, a technique includes accessing sensor data including a plurality of analyte readings of the host during a plurality of time periods, wherein each analyte reading is indicative of an analyte level of the host at a respective time. The technique further includes generating a first user interface (UI) view comprising one or more UI elements based on the plurality of analyte levels of the host, and, in response to receiving a user selection of a pregnancy mode, automatically modifying a parameter of at least one UI element included in the one or more UI elements to reflect a pregnancy-specific parameter. The technique further includes generating a second UI view based on the plurality of analyte levels of the host and the pregnancy-specific parameter.

Abstract: An implantable sensing device may include a housing. An implantable sensing device may include onboard electronics including one or more sensors carried by the housing. An implantable sensing device may include one or more anchoring features coupled to the housing and extending outward thereof, wherein the one or more anchoring features are configured to engage with the bone at a medullary canal thereof to couple the implantable device with the bone.

Abstract: Provided are sleep quality assessment methods, apparatuses, electronic devices, and storage medium, and relates to the field of artificial intelligence and deep learning technologies, and in particular to sleep quality assessment methods, apparatuses, electronic devices, and storage medium. The method includes: determining sleep data of a subject; obtaining sleep feature data based on a reference core sleep period of the subject and the sleep data; and evaluating sleep quality of the subject based on the sleep feature data. The method assesses the sleep quality of the subject based on the sleep feature data extracted based on the reference core sleep period of the subject and the sleep data of the subject, takes into account individual factors of the subject in extracting the sleep feature data, thus providing a more accurate assessment of the sleep quality of the subject.

Abstract: The present disclosure relates to a system and method for improving sleep quality, and particularly, to a system and method for improving sleep quality that can induce correct sleep behavior of a user by measuring objective sleep quality in a wearless state and measuring and analyzing subjective sleep quality in a user-friendly manner. The system for improving sleep quality according to an embodiment of the present disclosure includes: a mattress configured to measure objective sleep quality information of a user in a wearless type; a behavior correction assistance device disposed at a predetermined distance from the mattress; and an AI speaker configured to integrate and analyze objective sleep quality information measured by the mattress and subjective sleep quality information determined through Q&A with the user.

Abstract: Systems and methods for treating a subject with a psychiatric disorder are provided in winch a therapy session is conducted. In the therapy session, each respective expression image in a plurality of expression images is sequentially displayed. Each expression image is independently associated with an expression. The successive display of images is construed as a tiled series of expression image subsets, each consisting of N expression images. Upon completion of the display of each respective subset, the user is challenged as to whether the first and the last images in the respective subset exhibit the same emotion. A score is determined for the respective subset based on whether the subject learned to respond correctly. The number of images in each subset is adjusted to a new number based on these scores. A treatment regimen is prescribed to the subject for the psychiatric disorder based at least in part on the scores.

Abstract: Systems, methods and/or devices for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen.

Abstract: Devices, systems and methods are provided to assist with the monitoring or management of a patient's medical condition, which have one or more sensors sensing individual patient data on or near the patient. This individual patient data corresponds to at least one physiological parameter of the patient and includes a sensor that does not require the patient to apply it or activate it. The data is then transmitted to a processor for computing a risk or status signal that is based on comparison from a baseline related to a patient or related population and an alert or alarm can be generated based on the result of the signal.

Abstract: This disclosure is directed to devices, systems, and techniques for determining an efficacy of a treatment program. For example, a medical device system includes a medical device including one or more sensors configured to generate a signal that indicates a parameter of a patient. Additionally, the medical device system includes processing circuitry configured to receive data indicative of a user selection of a reference time; determine a plurality of parameter values of the parameter based on a portion of the signal corresponding to a period of time including the reference time. Additionally, the processing circuitry is configured to identify, based on a first set of parameter values, a reference parameter value, calculate a parameter change value, and determine, based on the parameter change value, whether an improvement or a worsening of the patient has occurred responsive to a treatment administered beginning at the reference time.

Abstract: A neurofeedback method and associated system for modulating brain activity includes functionally locating at least two brain networks in an adolescent subject which are associated with affective disorder symptoms during adolescence. Signals are recorded from each of the brain networks while the subject is performing a mediation task. An activity metric is determined based on a difference derived from the recorded signals, wherein changes in the activity metric over time are indicative of changes in relative activity level of the brain networks. Neurofeedback is provided by delivering a representation of the activity metric to the subject during the recording, thereby modulating brain activity in the subject.

Abstract: A patient health management platform accesses a metabolic profile for a patient and biosignals recorded for the patient during a current time period comprising sensor data and/or lab test data collected for the patient. The platform receives patient data recorded during the current time period comprising food items consumed, medications taken, and symptoms experienced by the patient. The platform implements a machine-learned metabolic model to determine a metabolic state of the patient at a conclusion of the current time period by comparing a true representation of the metabolic state and a prediction of the metabolic state. The true representation and the prediction are determined based on the recorded biosignals and the recorded patient data, respectively. The platform generates a patient-specific treatment recommendation outlining instructions for the patient to improve their metabolic state and provides the patient-specific treatment recommendation to the patient device for display to the patient.

Abstract: A smart wearable device has a signal calibration function executed by a signal calibration method and applied to a finger, a limb and/or a neck of a user. The smart wearable device includes at least one physiological signal detector, at least one pressure detector and an operation processor. The at least one physiological signal detector is adapted to abut against a detection area of the user for detecting a physiological signal. The at least one pressure detector is disposed around the at least one physiological signal detector and adapted to detect a pressure value of the detection area. The operation processor is electrically connected with the at least one physiological signal detector and the at least one pressure detector. The operation processor is adapted to optimize the physiological signal when the pressure value exceeds a predefined pressure threshold.

Abstract: The present technology is directed to measuring, estimating, or otherwise determining extravascular lung water (EVLW) in a patient. The systems can include a first device configured to be implanted in the patient and a second device configured to remain external to the patient. The first device can transmit electromagnetic energy, receive electromagnetic energy, or both transmit and receive electromagnetic energy. Likewise, the second device can receive electromagnetic energy, transmit electromagnetic energy, or both receive and transmit electromagnetic energy. In operation, an electromagnetic energy transmission pathway between the first device and the second device can include the patient's lungs. Accordingly, the system can determine EVLW in the patient based at least in part on an attenuation or phase shift of electromagnetic energy transmitted between the first device and the second device along the transmission path.

Abstract: This disclosure generally relates to systems and methods for detecting, monitoring, and responding to abnormalities in a subject's breathing or heartbeat. One or more sensing devices may collect breathing or heartbeat related data, which may be filtered and converted to a frequency signal. The frequency signal may be monitored for irregularity or stoppage, and a processing module may determine whether the irregularity or stoppage is caused by an actual stoppage or irregularity in breathing or heartbeat. If breathing or heartbeat is determined to have stopped, a corrective action may be performed.

Abstract: Various systems are provided for a support assembly for a medical imaging system. In one example, a system comprising, a support assembly for use with an imaging system, the support assembly comprising, a cradle including a base and opposing sidewalls, and a plurality of pads shaped to seat against the base within an opening formed between the opposing sidewalls, where each pad of the plurality of pads supports a head or extremity of a subject to be imaged at a different angle relative to the base.

Abstract: Provided is a biological signal measurement device capable of suppressing an influence of noise derived from a body motion of a test subject on a biological signal measurement result. The biological signal measurement device includes a placement portion on which a test subject is placed, one or more measurement sensors configured to measure a biological signal regarding the test subject, and a sensor holder configured to hold the measurement sensors. The placement portion has a recess. At least a part of the measurement sensor is arranged inside of the recess of the placement portion. The sensor holder and the measurement sensors are arranged to be physically separated from the placement portion without coming into contact with the placement portion.